Yi He

The selective hypoxia inducible factor-1 inhibitor PX-478 provides<i>in vivo</i>radiosensitization through tumor stromal effects

Garth Powis, Arun Thitai-Kumar, Yi He et al. · Molecular Cancer Therapeutics · 2009 · 97 citations · Full text

Medicine, Oncology, Pharmacology +15

Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer

James A. Bankson, Robert Lemos, Stephen Y. Lai et al. · Molecular Cancer Therapeutics · 2010 · 93 citations · Full text

Medicine, Oncology, Pharmacology +17

An apparatus to measure in vivo biomechanical behavior of dorsi- and plantarflexors of mouse ankle

James A. Ashton‐Miller, Yi He, V. Kadhiresan et al. · Journal of Applied Physiology · 1992 · 77 citations

Health Professions, Anatomy, Physiology +15

Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study

Xiaoqing Yan, Ming Ye, Qing Zou et al. · Annals of Oncology · 2023 · 75 citations · Full text

Medicine, Oncology, Pharmacology +13

Identification of prognostic genes in kidney renal clear cell carcinoma by RNA-seq data analysis

Yanqin Gu, Lu Linfeng, Lingfeng Wu et al. · Molecular Medicine Reports · 2017 · 55 citations · Full text

Life Sciences, Bioinformatics, Oncology +15